儿童和年轻人的近乎致命性喘:国际eDelphi研究
Ann McMurray1,2, Louise Fleming2,3, Steve Cunningham4,5
1Respiratory and Sleep Medicine, Royal Hospital for Children and Young People, Edinburgh, Edinburgh, UK.
Archives of disease in childhood
|March 6, 2025
概括
研究人员建立了一个共识的定义和首选名称",近乎致命的喘" (NFA),用于儿童和年轻人的严重喘发作. 这旨在改善对这个脆弱群体的护理.
科学领域:
- 儿科呼吸系统医学 儿科呼吸系统医学
- 关键护理医学 关键护理医学
- 喘研究 喘研究
背景情况:
- 在儿童和青少年 (CYP) 中,严重的喘发作往往是致命的结果.
- 对最严重的喘发作缺乏普遍接受的定义和名称.
- 这种差距阻碍了CYP中严重喘恶化症的有效表征和管理.
研究的目的:
- 在CYP中建立严重喘发作的共识名称和定义.
- 通过标准化术语来为临床实践和研究提供信息.
- 改进对发生危及生命的喘事件的CYP患者的鉴定和护理.
主要方法:
- 对文献,指导方针和多媒体报告进行了结构化审查,确定了潜在的术语和定义.
- 一个涉及专家顾问的国际电子Delphi (eDelphi) 过程进行了三轮.
- 共识被定义为在1-5利克尔特等级上达成≥70%的共识,并为额外输入提供自由文本.
主要成果:
- 范围审查确定了52项研究和27条指导方针,产生了41项项目和4个潜在的名称.
- 104名专家参与者完成了 eDelphi 流程的所有三轮.
- 接近致命性喘 (NFA) 成为首选名称 (66.7%),79.8%的参与者同意达成共识定义.
结论:
- 这项研究成功地确定了儿童和年轻人近乎致命性喘 (NFA) 的首选名称和共识定义.
- 开发的定义和名称将有助于更好地描述严重喘发作.
- 预计改进的特征将提高对严重喘患者的CYP护理的提供.
相关概念视频
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
314
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
314
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
211
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
211
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K


